NCT07278882Recruiting
Using Mobile Technology-assisted Outpatient Maintenance Therapy Pediatric ALL
A Randomized Controlled Trial of Mobile Technology-assisted Outpatient Maintenance Therapy in Children With Acute Lymphoblastic Leukaemia (ALL)
Source: ClinicalTrials.gov · Last updated 20 Oct 2026
Brief summary (registry, in English)
To assess the efficacy of using mobile technology to improve the percentage of time wherein drug dosing is within the target range
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 18 Nov 2025
- Start date
- 1 Dec 2025
- Primary completion date
- 20 Nov 2027
- Lead sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- NCT number
- NCT07278882
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 1 Dec 2025 to the primary completion date, 20 Nov 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None
Who the study is looking for
- \< 16 years old at diagnosis;
- having demonstrated ≥ 3 months of \> 90% compliance with using a mobile app to log in records of daily medication and weekly blood test results;
- no further in-hospital chemotherapy;
- patient or legal guardian provides informed consent.
Age in the registry: - to 16 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institute of Hematology & Blood Diseases Hospital Coordinator of this site? Confirm its status | Tianjin | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.